As of 2025-03-21, the Relative Valuation of Biosynex SA (ALBIO.PA) is (1.45) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.52 EUR, the upside of Biosynex SA based on Relative Valuation is -195.4%.
The range of the Relative Valuation is (1.49) - (10.25) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.7x - 4.9x | 0.9x |
| Forward P/E multiples | 0.4x - 6.3x | 0.5x |
| Fair Price | (1.49) - (10.25) | (1.45) |
| Upside | -198.2% - -773.4% | -195.4% |
| Date | P/E |
| 2025-03-14 | -0.77 |
| 2025-03-13 | -0.76 |
| 2025-03-12 | -0.78 |
| 2025-03-11 | -0.78 |
| 2025-03-10 | -0.78 |
| 2025-03-07 | -0.78 |
| 2025-03-06 | -0.81 |
| 2025-03-05 | -0.84 |
| 2025-03-04 | -0.81 |
| 2025-03-03 | -0.90 |
| 2025-02-28 | -0.72 |
| 2025-02-27 | -0.73 |
| 2025-02-26 | -0.61 |
| 2025-02-25 | -0.60 |
| 2025-02-24 | -0.61 |
| 2025-02-21 | -0.57 |
| 2025-02-20 | -0.59 |
| 2025-02-19 | -0.57 |
| 2025-02-18 | -0.56 |
| 2025-02-17 | -0.55 |
| 2025-02-14 | -0.61 |
| 2025-02-13 | -0.62 |
| 2025-02-12 | -0.59 |
| 2025-02-11 | -0.55 |
| 2025-02-10 | -0.56 |
| 2025-02-07 | -0.57 |
| 2025-02-06 | -0.56 |
| 2025-02-05 | -0.54 |
| 2025-02-04 | -0.53 |
| 2025-02-03 | -0.55 |
| 2025-01-31 | -0.61 |
| 2025-01-30 | -0.61 |
| 2025-01-29 | -0.53 |
| 2025-01-28 | -0.54 |
| 2025-01-27 | -0.61 |
| 2025-01-24 | -0.72 |
| 2025-01-23 | -0.67 |
| 2025-01-22 | -0.65 |
| 2025-01-21 | -0.80 |
| 2025-01-20 | -1.02 |
| 2025-01-17 | -0.99 |
| 2025-01-16 | -1.01 |
| 2025-01-15 | -0.94 |
| 2025-01-14 | -1.06 |
| 2025-01-13 | -0.95 |
| 2025-01-10 | -1.02 |
| 2025-01-09 | -1.05 |
| 2025-01-08 | -1.01 |
| 2025-01-07 | -1.03 |
| 2025-01-06 | -1.11 |